C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells. J. Anal. Oncol. 2013;2(4):195-208. doi:10.6000/1927-7229.2013.02.04.2